BioPartnering North America--Spotlight on Canada
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/20191430
其他信息:
PMID: 20191430
作者: Léonie Croydon; Léonie Croydon; Léonie Croydon
摘要: The BioPartnering North America conference, held in Vancouver, included presentations covering drug pipeline developments from both large and small pharmaceutical companies. This conference report highlights selected presentations from drug developers from Canada. Investigational drugs discussed include davunetide (Allon Therapeutics Inc), ANG-1005 (Angiochem Inc), AQX-1125 (Aquinox Pharmaceuticals Inc), and Sertolin (Sernova Corp), APG-2305 (Allostera Pharma Inc). The DepoVax liposomal vaccine ...

